EU Safety Gate (RAPEX) · Austria · 2025-01-31 · Serious risk
🌐Machine-translated with AI — the facts come from the issuing authority’s own notice (linked on this page); this language version was translated automatically by an AI model and is not reviewed. The original-language notice is authoritative. How we use AI →
Reported risk: Das Produkt enthält 2-Hydroxyethylmethacrylat (HEMA) und Hydrochinonmethylether (Mequinol), die in Nagelprodukten für Verbraucher verboten sind. HEMA verursacht schwere Augenreizungen, Hautreizungen und kann allergische Hautreaktionen hervorrufen. Mequinol ist gesundheitsschädlich bei Verschlucken, verursacht schwere Augenreizungen und kann allergische Hautreaktionen hervorrufen. Das Produkt entspricht nicht der Verordnung über kosmetische Mittel.
Action taken by the authority
Type of economic operator to whom the measure were ordered
Distributor
Category of measure
Removal of this product listing by the online marketplace
Date of entry into force
18/12/2024
Machine translation. This page was translated automatically from the English record we hold of the issuing authority’s notice. The English original is shown below and the authority’s own notice is linked above — both take precedence over this translation.
Product Name (original English): GEL COLOR GLITTER
Risk Description (original English): The product contains 2-hydroxyethyl methacrylate (HEMA) and hydroquinone methylether (mequinol), which are prohibited in nail products for consumer use. HEMA causes serious eye irritation, skin irritation and may cause allergic skin reaction. Mequinol is harmful if swallowed, causes serious eye irritation and may cause allergic skin reaction.
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.